Diagnosis, Treatment, and Clinical Outcome of Patients with Mitochondrial Trifunctional Protein/Long-Chain 3-Hydroxy Acyl-CoA Dehydrogenase Deficiency-Reference-Cited by-同舟云学术

Diagnosis, Treatment, and Clinical Outcome of Patients with Mitochondrial Trifunctional Protein/Long-Chain 3-Hydroxy Acyl-CoA Dehydrogenase Deficiency

Published:2016 Issue: Volume: Page:63-71
ISSN:2192-8304
Container-title:JIMD Reports
language:
Short-container-title:

Author:

De Biase Irene,Viau Krista S.,Liu Aiping,Yuzyuk Tatiana,Botto Lorenzo D.,Pasquali Marzia,Longo Nicola

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/8904_2016_558

Reference19 articles.

1. American College of Medical Genetics Newborn Screening Expert Group (2006) Newborn screening: toward a uniform screening panel and system--executive summary. Pediatrics 117:S296–S307

2. Bakermans AJ, van Weeghel M, Denis S, Nicolay K, Prompers JJ, Houten SM (2013) Carnitine supplementation attenuates myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice. J Inherit Metab Dis 36:973–981

3. Borghi E, de Onis M, Garza C et al (2006) Construction of the World Health Organization child growth standards: selection of methods for attained growth curves. Stat Med 25:247–265

4. den Boer ME, Wanders RJ, IJlst L, Morris AA, Heymans HS, Wijburg FA (2002) Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics 109:99–104

5. Fahnehjelm KT, Holmstrom G, Ying L et al (2008) Ocular characteristics in 10 children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a cross-sectional study with long-term follow-up. Acta Ophthalmol 86:329–337

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurological outcome in long‐chain hydroxy fatty acid oxidation disorders;Annals of Clinical and Translational Neurology;2024-01-23

2. Exercise testing and prescription in patients with inborn errors of muscle energy metabolism;Journal of Inherited Metabolic Disease;2023-07-02

3. Peroxisome proliferator-activated receptor (PPAR) agonists as a potential therapy for inherited metabolic disorders;Biochemical Pharmacology;2023-03

4. Anthropometric Parameters in Patients with Fatty Acid Oxidation Disorders: A Case–Control Study, Systematic Review and Meta-Analysis;Healthcare;2022-11-30

5. Effectiveness of Robotic-Assisted Gait Training and Aquatic Physical Therapy in a Child With Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency: A Case Report;Pediatric Physical Therapy;2022-08-30